(Q43038371)

English

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial

scientific article published in October 2010

Statements

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial (English)
R Burgos-Vargas
R Westhovens
A Chalmers
D D'Cruz
D J Wallace
J-C Becker
S Kelly
K Raghupathi
M Kinaszczuk
1 October 2010
3077-3087

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit